INTENSITY THERAPEUTICS, INC. Operating Income Loss

Quick Answer

INTENSITY THERAPEUTICS, INC. reported Operating Income Loss of -$11.97 million for the year ending 2025.

  • INTENSITY THERAPEUTICS, INC. showed an increase of +27.8% in Operating Income Loss from 2024 to 2025.
  • This data is from INTENSITY THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
  • XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2022 to 2025), INTENSITY THERAPEUTICS, INC.'s Operating Income Loss has declined by 58.6%.
  • Historical annual values: Fiscal year 2025: -$11.97 million | Fiscal year 2024: -$16.59 million | Fiscal year 2023: -$8.32 million | Fiscal year 2022: -$7.55 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: